ArticleBMJ (Clinical research ed.)2022

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.